Intri guingly, the overe pressed AMPK B1 that was found in early stages of ovarian cancer were significantly reduced in advanced stage ovarian cancer. Given that post translation modifications of AMPK B1 are essential for AMPK activity, the e pression status of AMPK B1 may determine the AMPK activity in ovarian cancer progression. In this study, we further investigated the e pression and functional roles of the AMPK B1 subunit in ovarian cancer. We demonstrated a progressive reduction in the e pression of the AMPK B1 subunit from early to late stage ovarian cancer, whereas enforced e pression of AMPK B1 could inhibit the cell growth and other aggressive capacities of ovarian cancer cells through the AKT ERK and JNK sig naling pathways.

Overall, our findings underscore the im portance of AMPK B1 in carcinogenesis through its ability to modulate AMPK Inhibitors,Modulators,Libraries activity and other oncogenic pathways during the progression of ovarian cancer. Materials and methods Ovarian cancer tissue array and cancer cell lines Four ovarian cancer cell lines were used A2780cp and OV2008 were obtained from Prof. B. K. Tsang, and SKOV3 and OVCA433 were obtained from ATCC. Cell line authentication was per formed using an in house STR DNA profiling analysis, and the cell lines were cultured Inhibitors,Modulators,Libraries in minimum essential medium supplemented with 10% FBS inside GSK-3 an incubator containing 5% CO2 at 37 C. An ovarian cancer tissue array, which consists of five cases of normal benign tumors and 97 cases of ovarian cancers, was used for immunohisto chemical analysis. Plasmids and DNA transfection The pcDNA3.

1 Inhibitors,Modulators,Libraries AMPK B1 Flag tagged plasmid was used to overe press AMPK B1 in ovarian cancer cells, and Li pofectamine 2000 Transfection Reagent was used for transfection e periments. Stable AMPK Inhibitors,Modulators,Libraries B1 over e pressing clones were established from AMPK B1 trans fected cells using G418 selection. The shRNA plasmid shRNA AMPK B1 for targeting against AMPK B1 was purchased from OriGene Technologies, Inc. Stable, AMPK B1 knockdown clones were established by puromycin selection of shB1 transfected cells, and all of the clones were verified by western blot analysis. The pEGFP AMPK B1 plasmid was used for im munofluorescence analysis and was constructed by sub cloning AMPK B1 from the pcDNA3. 1 AMPK B1 Flag tagged plasmid into pEGFP C1. Western blot, immunofluorescence and immunohistochemical analyses Cells were lysed in lysis buffer containing a protease inhibi tor and phenyl methyl sulfonyl fluoride. Equal amounts of each sample were fractionated by SDS PAGE and electroblotted onto an Immobilon P Membrane. The membrane was blocked with 5% non fat dry milk in a TBS with Tween solution at room temperature for 1 h, followed by overnight incubation with various primary antibodies.